Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia.
Pepeler MS, Tıglıoglu M, Dagdas S, Ozhamamcıoglu E, Han U, Albayrak A, Aydın MS, Korkmaz G, Pamukcuoğlu M, Ceran F, Albayrak M, Ozet G. Pepeler MS, et al. Among authors: tiglioglu m. Clin Lymphoma Myeloma Leuk. 2024 Apr;24(4):e161-e167. doi: 10.1016/j.clml.2023.12.015. Epub 2024 Jan 17. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38342726
The utility of CONUT score in indolent lymphoma patients.
Tiglioglu M, A Öztürk HB, Yıldız A, Tığlıoğlu P, Yılmaz F, Aras MR, Albayrak M. Tiglioglu M, et al. Niger J Clin Pract. 2023 Sep;26(9):1290-1296. doi: 10.4103/njcp.njcp_20_23. Niger J Clin Pract. 2023. PMID: 37794541 Free article.
Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study.
Acar R, Paydaş S, Yıldırım M, Kılıçarslan E, Sahın U, Dogan A, Guven DC, Ekıncı O, Tıglıoglu M, Erdogan I, Elıbol T, Kızıloz H, Aykan MB, Sayın S, Kaptan K, Soydan E, Gokmen A, Esen R, Barısta I, Albayrak M, Erturk I, Yıldız B, Keskın GY, Aylı M, Karadurmus N. Acar R, et al. Among authors: tiglioglu m. J Cancer Res Ther. 2023 Apr;19(Supplement):S138-S144. doi: 10.4103/jcrt.jcrt_355_22. J Cancer Res Ther. 2023. PMID: 37147993 Free article.
The outcome of COVID-19 in patients with hematological malignancy.
Tığlıoğlu P, Albayrak M, Tığlıoğlu M, Öztürk HBA, Aras MR, Sağlam B, Maral S. Tığlıoğlu P, et al. Among authors: tiglioglu m. Memo. 2022;15(1):83-89. doi: 10.1007/s12254-021-00775-5. Epub 2021 Dec 9. Memo. 2022. PMID: 34904019 Free PMC article.
Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment.
Yılmaz F, Albayrak M, Tığlıoğlu P, Tığlıoğlu M, Sağlam B, Reis Aras M, Maral S, Afacan Öztürk HB. Yılmaz F, et al. Among authors: tiglioglu m. J Oncol Pharm Pract. 2022 Apr;28(3):725-728. doi: 10.1177/10781552211060730. Epub 2021 Nov 13. J Oncol Pharm Pract. 2022. PMID: 34775854
14 results